Study of Standard and Individualized Treatment Model for Relapse and Refractory Lymphatic System Malignant Tumors
Clinical trial NCT02929615 · UNKNOWN
Trial details
- NCT number
- NCT02929615
- Sponsor
- Peking University
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2015-06-01
- Primary completion
- 2017-12-01
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.